Kimberly Shriner, MD; Matthew Bidwell Goetz, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: A recent issue featured two prospective, randomized studies comparing intravenous and inhaled pentamidine as primary therapy for Pneumocystis carinii pneumonia (1, 2). Both Soo Hoo and colleagues (1) and Conte and associates (2) demonstrated that intravenous pentamidine was superior to inhaled pentamidine for treatment of mild to moderate P. carinii pneumonia. However, although the clinical characteristics and disease activity of the inhaled and intravenous pentamidine groups were carefully described and well matched, little or no mention was made of concomitant corticosteroid use in either study other than the statement by Soo Hoo and colleagues (1) that one
Shriner K, Goetz MB. Pentamidine for Pneumocystis Pneumonia. Ann Intern Med. ;113:992–993. doi: 10.7326/0003-4819-113-12-992_2
Download citation file:
Published: Ann Intern Med. 1990;113(12):992-993.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use